Diabetes UK is calling on the government to put diabetes at the heart of its Major Conditions Strategy, as cases top five million for the first time.
New research shows that the the risk of developing type 2 diabetes was 20% lower in people with pre-diabetes referred to the NHS Diabetes Prevention Programme (NDPP) when compared to similar patients not referred to NDPP.
NICE has recommended the use of hybrid closed loop systems for patients who are struggling to manage their type 1 diabetes, according to new draft guidance.
A new study has found an association between early diagnosis of diabetes and earlier menopause, and a later diabetes diagnosis with a later age at menopause.
Drugs used to treat type 2 diabetes could reduce the risk of dementia, according to a long-term study published in the journal BMJ Open Diabetes Research & Care.
Whey protein could aid in the dietary management of type 2 diabetes after new research shows a pre-made shot before meals helps control blood sugars.
A revolutionary hybrid closed loop system, also known as an 'artificial pancreas', is being piloted in 35 NHS diabetes centres to test whether the technology can help people with type 1 diabetes safely and effectively control their…
NICE has recommended the use of real-time continuous glucose monitoring for adults and children living with type 1 diabetes to help them manage their condition and at the same time reduce the need for finger prick testing by up to 50%
Periodontal disease is the sixth complication of diabetes mellitus, but has received little recognition to date from the medical profession. Doctors and dentists need to work more closely and recognise the importance of cross-referrals…
A systematic review and meta-analysis of 33 studies has revealed the impact of the Covid-19 pandemic on people living with type 1 (T1D) and type 2 diabetes (T2D).
The latest Diabetes UK Professional Conference took place between the 19th and 30th April 2021. The online event saw named lecturers and professional interest groups present on a range of topics in order to update and educate healthcare…
A study has shown that type 2 diabetes drug rosiglitazone is associated with an increased cardiovascular risk, especially for heart failure events.
Women with diabetes are five times more likely to get heart failure than women without diabetes. Whereas men with diabetes are two times more likely to get heart failure.
Nearly 30,000 people across the country with type 1 diabetes have received diabetes monitors so they do not have to carry out multiple painful finger-prick checks.
Black and ethnic minority people are not as likely to be prescribed newer medication for type 2 diabetes and have less monitoring compared to their white peers.